Protagonist Therapeutics Inc (PTGX)

NASDAQ · Biotechnology

157.84
-0.78 (-0.49%)
Updated Aug 18, 6:08 PM ET
AI Rating
Buy
Overall Score
67
Trend
75
Momentum
78
Risk
38

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 19, 2026 120 sessions Aug 14, 2026

AI Analysis

Protagonist Therapeutics Inc is trading at $157.84, down 0.49% on the session. The 50 day average sits at $126.34 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 70.1, which reads as overbought, and MACD is bullish crossover. Volume is below average.

The nearest support is around $130.63 with resistance near $155.53, so that band frames the current range. Average daily movement is roughly $5.64, or about 3.6% of the share price, which is what any stop placement has to allow for. The overall health score of 67 out of 100 combines a trend score of 75, momentum of 78 and a risk score of 38.

Technical indicators

RSI (14)
70.1
overbought
MACD
6.995
bullish crossover
SMA 20
140.63
SMA 50
126.34
SMA 200
--
unknown
ATR (14)
5.64
avg daily range
Support
130.63
Resistance
155.53
Volume vs 20d
0.82x
below average
Volatility
49.7%
annualised
1 month
+19.41%
3 months
+49.86%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.